Gavin J. Churchyard mainly focuses on Tuberculosis, Immunology, Internal medicine, Acquired immunodeficiency syndrome and Surgery. He is interested in Mycobacterium tuberculosis, which is a field of Tuberculosis. His Immunology study combines topics from a wide range of disciplines, such as Efavirenz and Virology.
As a part of the same scientific study, he usually deals with the Internal medicine, concentrating on Sputum and frequently concerns with Relative risk. Gavin J. Churchyard interconnects Cross-sectional study, Viral load, Public health and Risk factor in the investigation of issues within Acquired immunodeficiency syndrome. His studies deal with areas such as Mass screening, Comorbidity and Isoniazid as well as Surgery.
Tuberculosis, Internal medicine, Immunology, Acquired immunodeficiency syndrome and Surgery are his primary areas of study. His Tuberculosis research is multidisciplinary, incorporating perspectives in Incidence, Pediatrics and Intensive care medicine. His biological study spans a wide range of topics, including Intervention, Disease and Transmission.
His research integrates issues of Psychological intervention and Virology in his study of Immunology. His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Epidemiology, Health care, Cohort study and Public health. His Surgery research incorporates themes from Silicosis and Mass screening.
Gavin J. Churchyard mostly deals with Tuberculosis, Internal medicine, Sputum, Environmental health and Disease. Gavin J. Churchyard undertakes interdisciplinary study in the fields of Tuberculosis and Spirometry through his works. His Internal medicine research includes elements of Multiple drug resistance and Mycobacterium tuberculosis.
The concepts of his Environmental health study are interwoven with issues in Extensively drug-resistant tuberculosis, Mortality rate, Epidemiology and Psychological intervention. The study incorporates disciplines such as Research design and Incidence in addition to Disease. His Prospective cohort study research is multidisciplinary, incorporating elements of Immunology and Respiratory system.
His primary scientific interests are in Tuberculosis, Sputum, Cohort study, Intervention and Intensive care medicine. His study in Tuberculosis is interdisciplinary in nature, drawing from both Disease progression, Internal medicine, Disease and Hazard ratio. When carried out as part of a general Internal medicine research project, his work on Odds ratio, Clinical trial and Meta-analysis is frequently linked to work in Nucleic acid amplification technique, therefore connecting diverse disciplines of study.
His Sputum study incorporates themes from Test, Case definition, Medical physics and Generalizability theory. His research in Intervention intersects with topics in Demand creation, Tuberculosis prevention, Cause of death, Transmission and Public health. His Intensive care medicine study integrates concerns from other disciplines, such as Regimen, Pharmacotherapy, Bedaquiline, Pretomanid and Dosing.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The diarylquinoline TMC207 for multidrug-resistant tuberculosis.
Andreas H. Diacon;Alexander Pym;Martin Grobusch;Ramonde Patientia.
The New England Journal of Medicine (2009)
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.
Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn.
The Lancet (2009)
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.
Elizabeth L Corbett;Elizabeth L Corbett;Barbara Marston;Gavin J Churchyard;Kevin M De Cock;Kevin M De Cock.
The Lancet (2006)
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study
Wouter Hoefsloot;Jakko Van Ingen;Claire Andrejak;Kristian Ängeby.
European Respiratory Journal (2013)
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley.
The Lancet Respiratory Medicine (2017)
Achieving the health Millennium Development Goals for South Africa: challenges and priorities
Mickey. Chopra;Mickey. Chopra;Joy E. Lawn;Joy E. Lawn;David. Sanders;Peter. Barron.
The Lancet (2009)
Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies.
Haileyesus Getahun;Wanitchaya Kittikraisak;Charles M. Heilig;Elizabeth L. Corbett.
PLOS Medicine (2011)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips.
The New England Journal of Medicine (2014)
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
Glenda E. Gray;Mary. Allen;Zoe. Moodie;Gavin J. Churchyard.
Lancet Infectious Diseases (2011)
Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment
Eva Hnizdo;Tanusha Singh;Gavin Churchyard.
Thorax (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of London
Johns Hopkins University
University of London
University of Cape Town
National Health Laboratory Service
South African Medical Research Council
Aurum Institute
Fred Hutchinson Cancer Research Center
University of Western Australia
University of London
University of Zurich
University of Waikato
University of Padua
i-University Tokyo
University of Waterloo
University of Washington
East China University of Science and Technology
Polish Academy of Sciences
Delft University of Technology
University of Alberta
University of Bath
University of Calgary
Charité - University Medicine Berlin
University of North Carolina at Chapel Hill
University of Oxford
Harvard University